Table 1. Baseline characteristics of... | American Society of Hematology

Table 1.

Baseline characteristics of relapsed and refractory patients treated with haplo donors

No.	Age and sex	Previous therapy	Severity	Clonality PNH MK		Donor	ABO compatibility	CMV status
1	35 M	ATG/CsA	SAA	+	46XY	38 F, sister	Matched	Matched
2	52 M	ATG/CsA	SAA	+	46XY	50 M, brother	Matched	Matched
3	45 F	ATG/CsA	SAA	−	46XX	47 M, brother	Matched	Matched
4	27 F	ATG/CsA	SAA	+	46XX	24 M, brother	Matched	Matched
5	33 M	HiCY	vSAA	−	46XY	50 M, rather	Matched	Matched
6	17 M	HiCY	vSAA	+	46XY	56 F, mother	Matched	Mismatched (donor −)
7	54 M	ATG/CSA, EPAG	vSAA	−	46XY	71 M, brother	Matched	Matched
8	26 F	ATG/CSA, EPAG	SAA	+	46XX	58 F, mother	Bidirectional	Matched
9	59 M	ATG/CSA ×2, EPAG	SAA	−	t(13;21)	29 M, son	Minor mismatched	Matched
10	20 F	ATG/CsA	vSAA	+	46XX	45 M, father	Matched	Mismatched (donor −)
11	11 M	ATG/CsA	vSAA	−	46XY	52 M, father	Matched	Matched
12	69 M	ATG/CSA ×2, alemtuzumab, EPAG	SAA	+	Del13	42 M, son	Matched	Matched
13	11 M	ATG/CsA	vSAA	−	46XY	36 M, father	Matched	Matched
14	21 M	CSA	SAA	+	46XY	23 F, sister	Minor mismatched	Matched
15	11 M	ATG/CsA	SAA	−	46XY	34 F, mother	Matched	Mismatched (donor +)
16	5 M	ATG/CsA	SAA	−	46XY	32 F, mother	Matched	Matched
17	34 F	ATG/CsA ×3	vSAA	−	46XX	36 F, mother	Matched	Matched
18	31 F	Matched sibling BMT	vSAA	+	46XX	44 M, father	Matched	Mismatched (donor +)
19	7 M*	None (DKC, TERC mutation)	vSAA	−	46XY	30 F, mother	Matched	Matched
20	46 M	ATG/ CsA	vSAA	+	46XY	24 M, son	Matched	Matched

No.	Age and sex	Previous therapy	Severity	Clonality PNH MK		Donor	ABO compatibility	CMV status
1	35 M	ATG/CsA	SAA	+	46XY	38 F, sister	Matched	Matched
2	52 M	ATG/CsA	SAA	+	46XY	50 M, brother	Matched	Matched
3	45 F	ATG/CsA	SAA	−	46XX	47 M, brother	Matched	Matched
4	27 F	ATG/CsA	SAA	+	46XX	24 M, brother	Matched	Matched
5	33 M	HiCY	vSAA	−	46XY	50 M, rather	Matched	Matched
6	17 M	HiCY	vSAA	+	46XY	56 F, mother	Matched	Mismatched (donor −)
7	54 M	ATG/CSA, EPAG	vSAA	−	46XY	71 M, brother	Matched	Matched
8	26 F	ATG/CSA, EPAG	SAA	+	46XX	58 F, mother	Bidirectional	Matched
9	59 M	ATG/CSA ×2, EPAG	SAA	−	t(13;21)	29 M, son	Minor mismatched	Matched
10	20 F	ATG/CsA	vSAA	+	46XX	45 M, father	Matched	Mismatched (donor −)
11	11 M	ATG/CsA	vSAA	−	46XY	52 M, father	Matched	Matched
12	69 M	ATG/CSA ×2, alemtuzumab, EPAG	SAA	+	Del13	42 M, son	Matched	Matched
13	11 M	ATG/CsA	vSAA	−	46XY	36 M, father	Matched	Matched
14	21 M	CSA	SAA	+	46XY	23 F, sister	Minor mismatched	Matched
15	11 M	ATG/CsA	SAA	−	46XY	34 F, mother	Matched	Mismatched (donor +)
16	5 M	ATG/CsA	SAA	−	46XY	32 F, mother	Matched	Matched
17	34 F	ATG/CsA ×3	vSAA	−	46XX	36 F, mother	Matched	Matched
18	31 F	Matched sibling BMT	vSAA	+	46XX	44 M, father	Matched	Mismatched (donor +)
19	7 M*	None (DKC, TERC mutation)	vSAA	−	46XY	30 F, mother	Matched	Matched
20	46 M	ATG/ CsA	vSAA	+	46XY	24 M, son	Matched	Matched

F, female; M, male.

Denotes patient with inherited SAA.